Abstract:In his paper “Fostering responsible research practices is a shared responsibility of multiple stakeholders” (April 2018), Lex M. Bouter [[1]Bouter L. Fostering responsible research practices is a shared responsibility of multiple stakeholders.J Clin Epidemiol. 2018; 96: 143-146Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar] highlights and appeals for orchestrated efforts to foster responsible research. We applaud Bouter's scholarship on promoting transparency and openness in biomedical research, and we share the same concern on the current replicability crisis. The science development is inevitably imbued with errors, fabrications, and falsifications, which makes reproducibility essential by separating true science from mere anecdote and even pseudoscience. When scientists try to replicate previous studies, two scenarios will emerge: consistent if not exactly the same findings as the formers, or different or conflicting results. Regardless either due to misconducts or flawed research, irreproducibility, without proper explanations, often casts shadows on responsible research. This applies to both natural and social sciences. We echo Bouter's appeal that improving reproducibility requires persistent and adaptive efforts of all stakeholders in research ecosystem. And we believe this is particularly important for emerging science powers where academic misconducts are looming over their escalating R&D investment and scientific achievements (Hu et al. 2018) [[2]Hu G. Yang Y. Tang L. Retraction and research integrity education in China.Sci Eng Ethics. 2018; (Letter)https://doi.org/10.1007/s11948-017-0017-xCrossref PubMed Scopus (11) Google Scholar]. Fortunately, tremendous efforts facilitating research integrity and reproducibility have been put forth by major funding agencies, universities, and third parties globally. Take China for example. Over the last decade, the Chinese government has penned substantially stricter regulations combating research misconduct. A cornucopia of guidelines promulgated by a variety of government organizations has conveyed a clear signal of China's tighter stance fostering responsible research. Yet, prescription alone is not sufficient to deter prospective fraudsters and irresponsible researchers. All countries including China need to move beyond releasing guidelines and penalizing egregious cases. Orchestrated including institutionalizing research ethics and integrity training through education is critical in fostering responsible research in the long run. Download .xml (.0 MB) Help with xml files Data Profile Fostering responsible research practices is a shared responsibility of multiple stakeholdersJournal of Clinical EpidemiologyVol. 96PreviewIn their recent commentary, Wallach et al. explain that breaches of research integrity will typically do damage to the reliability and validity of biomedical research [1]. This may harm regulatory and clinical decision-making. Consequently health care and public health may suffer. They point out that prevalent questionable research practices like poor study design, low power and selective reporting probably do substantially more damage than the rare occurrence of the classical “deadly sins” of fabrication, falsification, and plagiarism. Full-Text PDF Unsuccessful replication is not a sign of research misconductJournal of Clinical EpidemiologyVol. 104PreviewI applaud Tang et al. for pointing out that in China—as is the case in Asia at large—interesting initiatives to foster research integrity are being taken [1]. In fact this is one of the main reasons that the 6th World Conference on Research Integrity will be held in Hong Kong ( www.wcri2019.org ). I'm also grateful for the opportunity to clarify some common misunderstandings about replicability and replication. Full-Text PDF

Retraction and Research Integrity Education in China

Research Misconduct Investigations in China's Science Funding System

Importance of Strengthening Research Integrity in Health Area

Causes and countermeasures of research-integrity problems in the new era: From the perspective of the culture of science

Promoting Research Integrity And Excellence In Chinese Hrm Studies

Perceptions of research integrity and the Chinese situation: In-depth interviews with Chinese biomedical researchers in Europe

Academic Integrity in China

Productivity Patterns, Collaboration and Scientific Careers of Authors with Retracted Publications in Clinical Medicine

A Role for Funders in Fostering China’s Research Integrity

A Comparative Study on Characteristics of Retracted Publications Across Different Open Access Levels

Collaboration and Its Influence on Retraction Based on Retracted Publications During 1978–2017

Analysis of research integrity management in large hospitals

Retraction: the "other Face" of Research Collaboration.

China conducts first nationwide review of retractions and research misconduct

Orchestrated Efforts to Foster Responsible Research

Retraction of Publication in Medical Journals:Current Situation and Principle

High retraction rate of Chinese articles: it is time to do something about academic misconduct

Research on the concept of research integrity in Chinese policy environment

The Effects of Anti-corruption Campaign on Research Grant Reimbursement: Regression Discontinuity Evidence from China

The Role and Path of University Academic Journals in Research Integrity Building

Improving Systems to Promote Research Integrity